Sep 12, 2024 4:15pm EDT 180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial Officer
Jul 30, 2024 8:00am EDT 180 Life Sciences Announces Positive Topline Results of a Clinical Pharmacology Study Testing a New Solid Formulation of CBD with Enhanced Oral Uptake
Jul 23, 2024 8:00am EDT 180 Life Sciences Granted an Additional Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements
Jul 02, 2024 8:30am EDT 180 Life Sciences Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements
Mar 14, 2024 8:30am EDT 180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
Feb 26, 2024 7:00am EST 180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance Plan
Dec 04, 2023 9:00am EST 180 Life Sciences Engages Financial Advisor to Explore Strategic Alternatives